Company profile for Cytocom

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Cytocom, Inc. is a clinical-stage biopharmaceutical company developing a new class of Immunotherapies targeting cancers, infectious diseases, and autoimmune disorders utilizing a new systems biology approach creating first-in-class or best-in-class therapies. Our therapies may be standalone therapies or may be adjunctive therapies that improve upon the efficacy and safety of standard of care. The Cytocom approach is to deploy ...
Cytocom, Inc. is a clinical-stage biopharmaceutical company developing a new class of Immunotherapies targeting cancers, infectious diseases, and autoimmune disorders utilizing a new systems biology approach creating first-in-class or best-in-class therapies. Our therapies may be standalone therapies or may be adjunctive therapies that improve upon the efficacy and safety of standard of care. The Cytocom approach is to deploy our patented therapies focused on the activation and rebalancing of the body’s immune system.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
3001 Aloma Ave. Winter Park, FL 32792
Telephone
Telephone
+1-888-629-4155
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Tides Asia

Tides Asia

Not Confirmed

envelop Contact Supplier

Tides Asia

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://endpts.com/statera-biopharma-gets-the-ok-to-resume-the-study-of-a-potential-stockpile-drug-for-lethal-radiation-exposure/

Nicole DeFeudis ENDPTS
02 Dec 2021
Cytocom to Become Statera BioPharma
Cytocom to Become Statera BioPharma

01 Sep 2021

// CONTRACT PHARMA

https://www.contractpharma.com/contents/view_breaking-news/2021-08-31/cytocom-to-become-statera-biopharma/?widget=listSection

CONTRACT PHARMA
01 Sep 2021
Cytocom to Become Statera BioPharma
Cytocom to Become Statera BioPharma

31 Aug 2021

// CONTRACT PHARMA

https://www.contractpharma.com/contents/view_breaking-news/2021-08-31/cytocom-to-become-statera-biopharma/?widget=listSection

CONTRACT PHARMA
31 Aug 2021

https://www.prnewswire.com/news-releases/cytocom-inc-reports-second-quarter-2021-financial-results-301355490.html

PR NEWSWIRE
16 Aug 2021

http://www.pharmabiz.com/NewsDetails.aspx?aid=141807&sid=2

PHARMABIZ
14 Aug 2021

https://www.contractpharma.com/contents/view_breaking-news/2021-08-13/cytocom-to-fund-research-and-lab-facilities-at-the-la-jolla-institute-for-immunology/?widget=listSection

CONTRACT PHARMA
13 Aug 2021

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty